Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis.
Ryan Ruiyang LingKollengode RamanathanJackie Jia Lin SimSuei Nee WongYing ChenFaizan AminShannon M FernandoDeborah J CookEddy FanRyan P BarbaroGraeme MacLarenKiran ShekarDaniel BrodiePublished in: Critical care (London, England) (2022)
The mortality rate for patients receiving ECMO for COVID-19-related ARDS has increased as the pandemic has progressed. The reasons for this are likely multifactorial; however, as outcomes for these patients evolve, the decision to initiate ECMO should include the best contextual estimate of mortality at the time of ECMO initiation.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- coronavirus disease
- sars cov
- respiratory failure
- end stage renal disease
- cardiovascular events
- mechanical ventilation
- chronic kidney disease
- ejection fraction
- newly diagnosed
- risk factors
- prognostic factors
- peritoneal dialysis
- cardiovascular disease
- decision making
- type diabetes
- intensive care unit
- adipose tissue
- patient reported outcomes
- skeletal muscle